A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

NCT04255433 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13299

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Tirzepatide
DRUG: Dulaglutide

Sponsor

Eli Lilly and Company